Skip to main content

Table 1 Eligibility criteria of the COSMO-PD trial

From: Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol

Inclusion criteriaExclusion criteria
• Participants aged 18 years or over at the date of screening
• Participants with ESKD who were undergoing PD by either automated peritoneal dialysis or continuous ambulatory peritoneal dialysis
• History of psychological illness or condition that interferes with the ability to understand or comply with the requirements of the study
• Recent (within 1 month) exit-site/tunnel infection or PD-related peritonitis
• Known hypersensitivity to or intolerance of chlorhexidine or mupirocin
• Current or recent (within 1 month) treatment with antibiotics administered by any route
• Nasal or exit-site carriage of mupirocin-resistant S. aureus or chlorhexidine-resistant s. aureus
  1. Abbreviations: ESKD end-stage kidney disease, PD peritoneal dialysis, S. aureus Staphylococcus aureus